SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017283
Filing Date
2022-11-10
Accepted
2022-11-10 07:10:53
Documents
52
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20220930x10q.htm   iXBRL 10-Q 1401539
2 EX-10.1 mist-20220930xex10d1.htm EX-10.1 178775
3 EX-31.1 mist-20220930xex31d1.htm EX-31.1 12317
4 EX-31.2 mist-20220930xex31d2.htm EX-31.2 12468
5 EX-32.1 mist-20220930xex32d1.htm EX-32.1 9442
  Complete submission text file 0001558370-22-017283.txt   5302048

Data Files

Seq Description Document Type Size
6 EX-101.SCH mist-20220930.xsd EX-101.SCH 28792
7 EX-101.CAL mist-20220930_cal.xml EX-101.CAL 27763
8 EX-101.DEF mist-20220930_def.xml EX-101.DEF 104670
9 EX-101.LAB mist-20220930_lab.xml EX-101.LAB 274151
10 EX-101.PRE mist-20220930_pre.xml EX-101.PRE 200888
46 EXTRACTED XBRL INSTANCE DOCUMENT mist-20220930x10q_htm.xml XML 988473
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 221374904
SIC: 2834 Pharmaceutical Preparations